Comparison of Pegasys Versus Peg-Intron for Treatment of Chronic Hepatitis C Genotype 4

NCT00502099 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

217

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: Pegylated interferon alpha 2a
DRUG: Ribavirin
DRUG: Pegylated interferon alpha 2 b plus ribavirin

Sponsor

Amr Hafez

Collaborators

[object Object]